
SandboxAQ brings its drug discovery models to Claude — no PhD in computing required
Two reports show SandboxAQ enabling Claude-based access to its drug-discovery AI models, aligning with a shift toward platform-enabled collaboration and broader clinician-ready...
Go-to-Market Edge
Ecosystem expansion via Claude integrationBuild: Pursue cross-ecosystem model integrations to broaden the addressable market and lock in partners
Invest: Opportunity to back platforms that lower access costs and accelerate downstream adoption
Watch: Competition may intensify with similar wrap-around access strategies; verify Claude-compatible deployment feasibility
Verify: Track downstream user adoption, checking for new workflows or labs adopting the integrated models